| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/16/2006 | EP1690935A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690934A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690932A1 Bone and/or joint disease-associated gene |
| 08/16/2006 | EP1690930A1 Method of harvesting rare cells from blood products |
| 08/16/2006 | EP1690929A1 Regeneration treatment system |
| 08/16/2006 | EP1690928A1 Laminated cell culture containing hepatocytes and method for detecting endocrine-like substance |
| 08/16/2006 | EP1690927A1 Natural killer cell lines and methods of use |
| 08/16/2006 | EP1690875A1 Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 08/16/2006 | EP1690874A2 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 08/16/2006 | EP1690546A2 Transplants for myocardial scars and method and cellular preparations therefor |
| 08/16/2006 | EP1689878A2 Method for maintaining low shear in a bioprocessing system |
| 08/16/2006 | EP1689871A2 Controlling gene expression in plastids |
| 08/16/2006 | EP1689865A2 A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto |
| 08/16/2006 | EP1689857A1 Compositions comprising fetal liver cells and methods useful for hcv infection |
| 08/16/2006 | EP1689856A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by wnt factors |
| 08/16/2006 | EP1689855A1 Tangential flow filtration devices and methods for stem cell enrichment |
| 08/16/2006 | EP1689854A2 Placental stem cells and uses thereof |
| 08/16/2006 | EP1689853A1 Sperm cell separation by electrophoresis |
| 08/16/2006 | EP1689779A2 Native immunoglobulin binding reagents and methods for making and using same |
| 08/16/2006 | EP1689776A2 Equine p-selectin glycoprotein ligand-1 and uses thereof |
| 08/16/2006 | EP1689461A1 Use of a hydrogel for the culture of chondrocytes |
| 08/16/2006 | EP1689431A1 Cytoprotective effects of ethyl pyruvate |
| 08/16/2006 | EP1689423A2 Regulation of sperm function |
| 08/16/2006 | EP1689377A2 Stem cell culture medium and method of using said medium and the cells |
| 08/16/2006 | EP1689346A2 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 08/16/2006 | EP1689321A2 Artificial tissue systems and uses thereof |
| 08/16/2006 | EP1689319A2 Bone and tissue scaffolding and method for producing same |
| 08/16/2006 | EP1689284A2 Method to control ventricular rate in atrial fibrillation patients |
| 08/16/2006 | EP1689228A2 Methods, compositions and devices for inducing stasis in cells |
| 08/16/2006 | EP1623222A4 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 08/16/2006 | EP1495112B1 Cell culture medium |
| 08/16/2006 | EP1397488B1 Novel compounds for chemiluminescense procedures |
| 08/16/2006 | EP1370641B1 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 08/16/2006 | EP1363930B1 A method for generating genetically altered antigens |
| 08/16/2006 | EP1309695B1 Polyketide synthases with altered specificity, their preparation and use |
| 08/16/2006 | EP1268545B1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 08/16/2006 | EP1268530B1 Hepatitis b core antigen fusion proteins |
| 08/16/2006 | EP1186301B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1115876B1 Receptor based antagonists and methods of making and using |
| 08/16/2006 | EP1064309B1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1053324B1 Novel cystine knot protein and materials and methods for making it |
| 08/16/2006 | EP1032651B1 INDUCIBLE CELLULAR IMMUNITY THROUGH ACTIVATION OF Th1 AND SUPPRESSION OF Th2 RESPONSES BY MACROPHAGES |
| 08/16/2006 | EP0972519B1 Immune tolerance inducers |
| 08/16/2006 | EP0952828B1 Therapeutic uses for nitric oxide inhibitors |
| 08/16/2006 | EP0836484B1 In vitro packaging of adeno-associated virus dna |
| 08/16/2006 | EP0827509B1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 08/16/2006 | EP0784690B1 Complementary adenoviral vector systems and cell lines |
| 08/16/2006 | EP0314705B2 A novel family of primate hematopoietic growth factors |
| 08/16/2006 | CN1820069A Selection and propagation of progenitor cells |
| 08/16/2006 | CN1820027A Emitter-binding peptides that produce a change in the spectral emission properties of the emitter |
| 08/16/2006 | CN1820022A Hepatitis c virus NS5B polymerase inhibitor binding pocket |
| 08/16/2006 | CN1820020A SARS-coronavirus virus-like particles and methods of use |
| 08/16/2006 | CN1819838A Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells |
| 08/16/2006 | CN1818071A Method for transferring bone marrow filling dry cell by TPO/FL |
| 08/16/2006 | CN1818058A In vitro cell culturing method |
| 08/16/2006 | CN1818057A Method for extracting pear pollen protoplast by enzymolysis |
| 08/16/2006 | CN1818054A Method and apparatus for destroying cell or virus |
| 08/16/2006 | CN1817900A Transcription factor for regulating plant fallen, its coding gene and use |
| 08/16/2006 | CN1817112A Fast lavandulol regeneration |
| 08/16/2006 | CN1817110A Cyrtopterin tissue culturing method and fast reproduction thereof |
| 08/16/2006 | CN1817109A Fast teething and reproduction for Mafeng tree |
| 08/16/2006 | CN1817106A Beiwuweizi cell embryo growth and strain regeneration |
| 08/16/2006 | CN1269962C Expression vector for siRNA of mammal cell |
| 08/16/2006 | CN1269960C Human FGF23 protein mutant lowering blood phosphorus level |
| 08/16/2006 | CN1269956C Non serum substratum for in vitro culture and amplification of cutaneous keratin cell |
| 08/16/2006 | CN1269955C Manufacture of hemoglobin-based oxygen carrier |
| 08/16/2006 | CN1269534C Chondric implant and production method thereof |
| 08/16/2006 | CN1269477C Inflammation-inhibiting compounds |
| 08/15/2006 | US7091407 Inbred corn line PH907 |
| 08/15/2006 | US7091406 For producing maize plants; resistance to diseases and insects, tolerance to heat and drought, reducing the time to crop maturity, greater yield, and better agronomic quality |
| 08/15/2006 | US7091405 Herbicide resistant corn plant; high yielding, agronomically sound plants |
| 08/15/2006 | US7091397 Nucleic acid molecules encoding polypeptides having the enzymatic activity of an RNA-directed RNA polymerase (RdRP) |
| 08/15/2006 | US7091396 Animals, cells and methods for production of detectably-labeled antibodies |
| 08/15/2006 | US7091333 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases |
| 08/15/2006 | US7091324 For diagnosis and therapy of HCV infection, including being useful in the identification of patients expected to benefit from certain therapeutic strategies |
| 08/15/2006 | US7091323 Human TIMP-1 antibodies |
| 08/15/2006 | US7091322 Human endometrial specific steroid-binding factor I, II, and III |
| 08/15/2006 | US7091317 Enhanced green fluorescent protein for use as diagnostic tool in monitoring gene expression, function and localization |
| 08/15/2006 | US7091038 Ecdysone receptor-based inducible gene expression system |
| 08/15/2006 | US7091033 Monitoring preferential gene expression profile; obtain cellsample, incubate with modulator, monitor gene expression profile, compare to control, evaluate gene expression |
| 08/15/2006 | US7091031 nucleic acid molecules encoding enzymes useful for microbial production of cyclic hydroxylated carotenoid compounds; crtZ gene, isolated from Brevundimonas vesicularis DC263 |
| 08/15/2006 | US7091029 Preparing adeno-associated viral vectors for gene therapeutic treatment of respiratory system disorders |
| 08/15/2006 | US7091027 Transgenic amorpha-4,11-diene synthesis |
| 08/15/2006 | US7091025 Malathion carboxylesterase |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7091019 The use of these proteins enables the transformation of a hop by gene manipulations as well as enables the in vitro synthesis of the secondary metabolites of a hop. |
| 08/15/2006 | US7091018 Enzyme gene and its expression product |
| 08/15/2006 | US7091007 Comprises nucleotide sequences coding bone morphogenic and serine/threonine receptor proteins for for identifying modulators for use in prevention and treatment of bone and/or cartilage disorders |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7091004 Regulation of translation for recombinant protein production |
| 08/15/2006 | US7090994 Methods of screening for introduction of DNA into a target cell |
| 08/15/2006 | US7090991 System for detection of a functional interaction between a compound and a cellular signal transduction component |
| 08/15/2006 | US7090986 identifying compounds such as antibodies that compete with the binding of Saratin to collagen by determining the binding of said Saratin to collagen in the presence or absence of a competitor. |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/15/2006 | US7090849 Babesia canis vaccine |
| 08/15/2006 | US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease |
| 08/15/2006 | US7090842 antigen-binding fragment comprises immunoglobulin variable region light chains and heavy chains, produced by hybridoma; fusion proteins |
| 08/15/2006 | US7090837 comprises attachment incompetent fusogenic polypeptide (lentivirus or influenza hemagglutinin) and heterologous targeting polypeptide (chimeric, with transmembrane cd40 domain); gag genes/proteins; pol genes/proteins; rev genes/proteins; gene therapy |